CAS 1613026-24-6

Formula: C42H60N2O4

InChI: InChI=1S/C42H60N2O4/c1-25(45)47-29-15-19-39(3)27(23-29)7-9-31-33-11-13-37(41(33,5)21-17-35(31)39)43-44-38-14-12-34-32-10-8-28-24-30(48-26(2)46)16-20-40(28,4)36(32)18-22-42(34,38)6/h7-8,29-36H,9-24H2,1-6H3/t29-,30-,31-,32-,33-,34-,35-,36-,39-,40-,41-,42-/m0/s1

InChI key: AHDQJVGOXSKEFD-RKQPAIJPSA-N

SMILES: CC(=O)O[C@H]1CC[C@@]2([C@H]3CC[C@]4([C@H]([C@@H]3CC=C2C1)CCC4=NN=C5CC[C@@H]6[C@@]5(CC[C@H]7[C@H]6CC=C8[C@@]7(CC[C@@H](C8)OC(=O)C)C)C)C)C

Despyridine Abiraterone Acetate Hydrazine Dimer (1,2-Hydrazinediylidenedi(3β,3'β)androst-5-en-3-yl-17-ylidene diacetate)

CAS: 1613026-24-6

Non-aromatic organic derivatives of hydrazine or of hydroxylamine(excluding drugs)

Formula: C₄₂H₆₀N₂O₄

Color and Shape: Off-White Solid

Molecular weight: 656.45531

Ref: 45-1A16760

Abiraterone Impurity 29

CAS: 1613026-24-6

Formula: C₄₂H₆₀N₂O₄

Molecular weight: 656.95

Ref: 4Z-A-8279

3Beta-17-Imino-androst-5-en-3-ol Acetate Dimer

Controlled Product

CAS: 1613026-24-6

Applications 3β-17-Imino-androst-5-en-3-ol Acetate Dimer is an impurity of Abiraterone (A108490), a steroidal cytochrome P 450 17α-hydroxylase-17,20-lyase inhibitor (CYP17). Abiraterone is currently undergoing phase II clinical trials as a potential drug for the treatment of androgen-dependent prostate cancer.
References Denis, L., et al.: Cancer, 72, 3888 (1993), Potter, G.A., et al.: J. Med. Chem., 38, 2463 (1995), Denmeade, S., et al.: Nat. Rev., 2, 389(2002), Scher, H., et al.: J. Clin. Oncol., 23, 8253 (2005)

Formula: C₄₂H₆₀N₂O₄

Color and Shape: Neat

Molecular weight: 656.94

Ref: TR-I399805

3β-17-Imino-androst-5-en-3-ol Acetate Dimer (1mg/ml in Acetonitrile)

Controlled Product

CAS: 1613026-24-6

Formula: C₄₂H₆₀N₂O₄

Color and Shape: Single Solution

Molecular weight: 656.94

Ref: TR-KIT5375

Abiraterone Acetate Di Acetoxy Dimer

CAS: 1613026-24-6

Formula: C₄₂H₆₀N₂O₄

Molecular weight: 656.95

Ref: ST-EA-CP-A67059